Active	Status	Sponsor type	Region	Phase	Filter
3 Active 42 Inactive 45 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
danusertib (PHA-739358) / Nerviano Medical Sciences
No trials found
aurora / FLT-3 inhib / Sareum
No trials found
MLN8054 / Takeda
No trials found
R04612910 / Roche
No trials found
AMG 900 / Amgen
No trials found
VE 465 / Merck (MSD)
No trials found
aurora inhibitor / BMS, Daiichi Sankyo
No trials found
CYC3 / Cyclacel
No trials found
A 60 / MabVax
No trials found
aurora A inhibitor / Elara
No trials found
TLK60404 / MabVax
No trials found
KW-2449 / Kyowa Kirin
No trials found
ilorasertib (ABT348) / AbbVie
No trials found
MP-529 / Otsuka
No trials found
TTP607 / vTv Therapeutics
No trials found
CCT137690 / Chroma Therap, Institute of Cancer Research
No trials found
SNS-314 / Viracta Therap
No trials found
cenisertib (AS703569) / Rigel
No trials found
CYC116 / Cyclacel
No trials found
SCH 1473759 / Merck (MSD)
No trials found
CCT129202 / Chroma Therap
No trials found
ENMD-2076 / CASI
No trials found
TAK-901 / Takeda
No trials found
tozasertib (MK-0457) / Merck (MSD)
No trials found
NMI-900 / Nemucore
No trials found
thiopyrano quinoline (MT477) / Medisyn Technologies
No trials found
luxeptinib (CG-806) / Aptose Biosci
No trials found
SU6656 / Pfizer, Hokkaido University
No trials found
EP0042 / Ellipses Pharma
No trials found